Access cutting-edge hypertrophic cardiomyopathy (hcm) treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Palo Alto location
Preparing your pre-screening questions…
Access hypertrophic cardiomyopathy (hcm) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hypertrophic cardiomyopathy (hcm) treatment provided free
Check if you qualify for this hypertrophic cardiomyopathy (hcm) clinical trial in Palo Alto, CA
No-Cost Study Care
Local to Palo Alto
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study evaluates the impact of large language models (LLMs) versus traditional decision support tools on clinical decision-making in cardiology. General cardiologists will be randomized to manage real patient cases from a cardiovascular genetic cardiomyopathy clinic, with or without AI assistance. Each case will be assessed by two cardiologists, and their responses will be graded by blinded subspecialty experts using a standardized evaluation rubric.
Sponsor: Stanford University
Yes, this clinical trial (NCT06935253) has an active research site in Palo Alto, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hypertrophic cardiomyopathy (hcm) treatment options in Palo Alto, CA, this clinical trial (NCT06935253) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypertrophic cardiomyopathy (hcm) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hypertrophic cardiomyopathy (hcm) clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Palo Alto — not just this study.
Browse Pulmonary Embolism Trials in Palo Alto →